Edition:
India

Myriad Genetics Inc (MYGN.OQ)

MYGN.OQ on NASDAQ Stock Exchange Global Select Market

33.74USD
8 Dec 2017
Change (% chg)

$0.67 (+2.03%)
Prev Close
$33.07
Open
$33.00
Day's High
$34.13
Day's Low
$32.46
Volume
310,593
Avg. Vol
327,686
52-wk High
$37.30
52-wk Low
$15.15

Select another date:

Wed, Nov 8 2017

BRIEF-Myriad Genetics posts Q1 adjusted earnings per share $0.26

* Myriad Genetics reports fiscal first-quarter 2018 financial results

BRIEF-Myriad announces GeneSight Psychotropic results from a large prospective trial in patients with major depressive disorder

* Myriad announces GeneSight® Psychotropic results from a large prospective trial in patients with major depressive disorder

BRIEF-‍Myriad Genetics announces new positive results for EndoPredict

* Endopredict (epclin) shown in second study to be more effective than oncotype dx® (rs) in women with intermediate risk of breast cancer recurrence

BRIEF-Myriad submits BRACAnalysis® CDx application for regulatory approval in Japan

* Myriad submits BRACAnalysis® CDX application for regulatory approval in Japan for HER2- metastatic breast cancer

BRIEF-Myriad Genetics’s supplementary PMA for BRACAnalysis CDx accepted by FDA for review

* Myriad’s BRACAnalysis CDx supplementary pma accepted by fda for review as a companion diagnostic for Lynparza (olaparib) in metastatic breast cancer

BRIEF-Myriad Genetics Inc announces launch of riskScore

* Myriad Genetics Inc - September 5, co announced it has launched riskScore - SEC filing Source text: (http://bit.ly/2eDj2Kj) Further company coverage:

BRIEF-EndoPredict receives positive coverage decisions from Medicare and Anthem

* EndoPredict receives positive coverage decisions from Medicare and Anthem

BRIEF-Myriad Genetics Q4 adjusted earnings per share $0.30

* Myriad Genetics reports fiscal fourth-quarter 2017 and fiscal full-year 2017 financial results

BRIEF-Agena Bioscience announces expanded partnership with Assurex Health

* Agena bioscience - assurex health, subsidiary of myriad genetics, has selected massarray system for streamlined laboratory set-up, sample processing of assurex health's genesight test

Select another date: